• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Syniverse Holdings

Syniverse Holdings

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Cigna's Demonstration of “Real World” Effectiveness for Hepatitis C New Drug Therapies Drives Affordability Strategies

    Cigna's Demonstration of “Real World” Effectiveness for Hepatitis C New Drug Therapies Drives Affordability Strategies

  2. Raining Liquidity on the ‘Ticker Tape-r’ Parade

    Syniverse Holdings SVR posted second-quarter results that mostly met our expectations. We are reiterating our opinion that this company has very little growth potential and no competitive advantage. We continue to be less than positive on the overall market for providing network services to ...

  3. Aethlon Medical® Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

    Aethlon Medical® Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

  4. March's Stock Red Flags

    Three stocks we think investors should be wary of.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.